Safety and Feasibility of the Supira System in High Risk Percutaneous Coronary Interventions: 1-Year Single Center Results From the US SUPPORT I EFS

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker’s Bureau - Abbott; Supira Medical; Adona Medical</li></ul>